(Q37655603)

21 August 2017

1 reference

title

Scleroderma renal crisis: a rare but severe complication of systemic sclerosis (English)

1 reference

21 August 2017

6

Loïc Guillevin

1 reference

21 August 2017

5

Peter M Villiger

1 reference

21 August 2017

Luc Mouthon

1

1 reference

21 August 2017

Alice Bérezné

series ordinal

2

1 reference

21 August 2017

Guillaume Bussone

series ordinal

3

1 reference

21 August 2017

Laure-Hélène Noël

series ordinal

4

1 reference

21 August 2017

1 April 2011

1 reference

Clinical Reviews in Allergy & Immunology

21 August 2017

1 reference

21 August 2017

40

1 reference

21 August 2017

2

1 reference

21 August 2017

84-91

1 reference

https://scigraph.springernature.com/pub.10.1007/s12016-009-8191-5

21 August 2017

0 references

cites work

Scleroderma renal crisis

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Scleroderma renal crisis: patient characteristics and long-term outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Normotensive renal failure in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Renal complications and scleroderma renal crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Systemic sclerosis: hypothesis-driven treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Abnormalities of renal physiology in systemic sclerosis. A prospective study with 10-year followup

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Factors predicting development of renal involvement in progressive systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Acute renal failure occurring in scleroderma treated with cyclosporin A: a report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Glucocorticoids regulate the expression of the human osteoblastic endothelin A receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Scleroderma: it has been a long hard journey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Prevalence of systemic sclerosis in a French multi-ethnic county

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

[Systemic sclerosis: epidemiology and environmental factors].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Predictors of end stage lung disease in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Thrombotic thrombocytopenic purpura in the setting of systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Renal vascular histology and morphometry in systemic sclerosis. A case-control autopsy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Long-term outcomes of scleroderma renal crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Scleroderma renal crisis, still a life-threatening complication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Predictors and risk factors for recurrent scleroderma renal crisis in the kidney allograft: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Changes in causes of death in systemic sclerosis, 1972-2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8191-5

Scleroderma renal crisis with minimal skin involvement and no serologic evidence of systemic sclerosis

21 January 2018

1 reference

12 December 2020

The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation.

1 reference

12 December 2020

D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects

1 reference

12 December 2020

MPO-ANCA-Positive crescentic glomerulonephritis: a distinct entity of scleroderma renal disease?

1 reference

12 December 2020

Renal vascular damage in systemic sclerosis patients without clinical evidence of nephropathy

1 reference

12 December 2020

Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases

1 reference

12 December 2020

Scleroderma--clinical and pathological advances

1 reference

12 December 2020

Systemic sclerosis sine scleroderma: an unusual presentation in scleroderma renal crisis

1 reference

12 December 2020

Pregnancy in women with systemic sclerosis

1 reference

12 December 2020

The kidney of scleroderma

1 reference

12 December 2020

Kidney disease other than renal crisis in patients with diffuse scleroderma

1 reference

12 December 2020

Failure of losartan to control blood pressure in scleroderma renal crisis

1 reference

12 December 2020

Pregnancy in women with systemic sclerosis

1 reference

12 December 2020

Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?

1 reference

12 December 2020

Immunohistological study endothelin-1 and endothelin-A and B receptors in two patients with scleroderma renal crisis

1 reference

12 December 2020

Renal scintigraphy in acute scleroderma: report of three cases

1 reference

12 December 2020

Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients

1 reference

12 December 2020

Evidence of activation of 2 herpesviruses, Epstein-Barr virus and cytomegalovirus, in systemic sclerosis and normal skins

1 reference

12 December 2020

Epidemiological study of patients with systemic sclerosis in Tokyo

1 reference

12 December 2020

Autoantibody reactive with RNA polymerase III in systemic sclerosis

1 reference

12 December 2020

Reversible scleroderma renal crisis after cocaine use

1 reference

12 December 2020

Pathologic observations concerning the kidney in progressive systemic sclerosis

1 reference

12 December 2020

10.1007/S12016-009-8191-5

Identifiers

DOI

1 reference

21 August 2017

1 reference